SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : JMED - Jones Pharma (specialty pharmaceutical mfr) -- Ignore unavailable to you. Want to Upgrade?

To: wbASSETt who wrote (240)2/10/2000 7:31:00 PM
From: Sr K  Respond to of 268
 
Closed out my remaining JMED options:

30 Mar 50's I bought Jan 26 for 2.6875 (I think the stock was 48.25 at the time). Took 18.125. I had hedged 20 of them Jan 28 selling 20 Feb 55's for what seemed smart (2.25) and rolled out of them Feb 7 for a $14,876 loss (got to have that "cut your losses" mentality on covered calls), but made $46k on the long position.

This is a great company, but the price was too enticing.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News